Monday, May 18, 2026

CMS has imposed a six-month nationwide freeze on new Medicare enrollments for all hospice and home health agencies effective May 15, 2026. The suspension is described as part of a fraud-sweep action. Newly enrolling providers cannot submit claims for reimbursement during this period. Existing providers are not affected, but practices planning to add these service lines or expand locations must halt those applications immediately. The freeze is scheduled to last until November 15, 2026. For billing teams, this means any new hospice or home health service contracts with a new Tax ID or NPI cannot be credentialed for Medicare reimbursement before that date.

Humana has issued a new Medicare coverage policy for Barostim neuromodulation therapy, a device-based treatment for resistant hypertension. The policy establishes national coverage criteria and sets the stage for claims adjudication. The move follows a CMS pricing decision for similar cardiac monitoring technologies, indicating payer focus on novel device reimbursement. For practices offering this therapy, confirm that Humana's clinical criteria match your patient selection protocols and prepare for potential pre-authorization requirements. Monitor for analogous coverage announcements from other major payers in the coming weeks.

Aetna has agreed to pay $117.7 million to settle Department of Justice allegations it submitted false claims to the Medicare Advantage program. The settlement resolves claims that the insurer inflated risk-adjustment payments by submitting inaccurate diagnosis data. This enforcement action signals continued DOJ and OIG scrutiny of Medicare Advantage coding and risk-adjustment practices, which can indirectly affect provider groups through payer audit and documentation review pressures. While not a direct action item for independent practices, it underscores the regulatory environment in which payers operate and may lead to more stringent chart reviews.

Former President Trump's campaign outlined a proposal tying future increases in defense spending to limits on Medicare and Medicaid funding. The policy framework suggests a shift toward capping entitlement program growth to offset military budget expansion. This creates a direct linkage between two major federal budget categories. The proposal signals a potential flashpoint in the 2026 budget negotiations, where entitlement program stability could be contingent on unrelated spending decisions. Monitor the congressional appropriations process for any formal legislative language linking Medicare/Medicaid funding caps to defense authorization bills.